Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 52 out of 100. Genetics

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

Introduction Most Alzheimer's disease (AD) loci have been discovered in individuals with European ancestry (EA). Methods We applied principal component analysis using Gaussian mixture models and an Ashkenazi Jewish (AJ) reference genome-wide association study (GWAS) data set to identify Ashkenazi Jews ascertained in GWAS (n = 42,682), whole genome sequencing (WGS, n = 16,815), and whole exome sequencing (WES, n = 20,504) data sets. The association of AD was tested genome wide (GW) in the GWAS and WGS data sets and exome wide (EW) in all three data sets (EW). Gene-based analyses were performed using aggregated rare variants. Results In addition to apolipoprotein E (APOE), GW analyses (1355 cases and 1661 controls) revealed associations with TREM2 R47H (p = 9.66 × 10 -9 ), rs541586606 near RAB3B (p = 5.01 × 10 -8 ), and rs760573036 between SPOCK3 and ANXA10 (p = 6.32 × 10 -8 ). In EW analyses (1504 cases and 2047 controls), study-wide significant association was observed with rs1003710 near SMAP2 (p = 1.91 × 10 -7 ). A significant gene-based association was identified with GIPR (p = 7.34 × 10 -7 ). Discussion Our results highlight the efficacy of founder populations for AD genetic studies.

What this study adds

Evidence grade: Moderate

This is a case-control study. In people of Ashkenazi Jewish ancestry, this study confirmed known Alzheimer's genes like APOE and TREM2 and found additional associations near RAB3B, SPOCK3, ANXA10, SMAP2, and GIPR. These results show that studying founder populations can help uncover genetic risk factors for Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Li, D., Farrell, J. J., Mez, J., Martin, E. R., Bush, W. S., Ruiz, A., et al. (2023). Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13117

Vancouver

Li D, Farrell JJ, Mez J, Martin ER, Bush WS, Ruiz A, et al. Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews. Alzheimer's & Dementia. 2023. doi:10.1002/alz.13117. PMID: 37260021.

BibTeX

@article{li2023-37260021,
  author  = {Li, D. and Farrell, J. J. and Mez, J. and Martin, E. R. and Bush, W. S. and Ruiz, A. and Boada, M. and de Rojas, I. and Mayeux, R. and Haines, J. L. and Vance, M. A. P. and Wang, L. S. and others},
  title   = {{Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews}},
  journal = {Alzheimer's \& Dementia},
  year    = {2023},
  doi     = {10.1002/alz.13117},
  pmid    = {37260021},
  url     = {https://doi.org/10.1002/alz.13117}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

In people of Ashkenazi Jewish ancestry, this study confirmed known Alzheimer's genes like APOE and TREM2 and found additional associations near RAB3B, SPOCK3, ANXA10, SMAP2, and GIPR. These results show that studying founder populations can help uncover genetic risk factors for Alzheimer's disease.

Study details

Limitations

Sample size is small compared with other AD GWAS; stringent ancestry boundaries excluded some individuals with substantial Ashkenazi ancestry; infrequent variants may have been poorly imputed in smaller cohorts; part of the data came from exome sequencing, reducing the sample for genome-wide analyses.

How this study scored 52/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 2 of 4; Study design 6 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 1 of 6; Still being cited 1 of 4; Senior author's track record 4 of 4; Institution's track record 2 of 3; Multicenter collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 51 of the 98 points it could be judged on, which is 52 of 100. Total 52 of 100.51 of the 98 points we could judge = 52 of 100

Published in a leading specialty journal, and it is a case-control study. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 51 of the 98 points we could judge it on, which is 52 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Alzheimer's & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 6 / 12 A case-control study
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2023 — within 6 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 8 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.6 citations a year over 5 year(s) since 2023
Impact for its field and year 2 / 6 Cited 1.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 1 / 4 Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Lindsay A. Farrer: h-index 119 (OpenAlex, whole career)
Institution's track record 2 / 3 University of Pennsylvania: institution h-index 1,859 (OpenAlex)
Multicenter collaboration 3 / 3 OpenAlex lists 11 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 37260021)
Free to read — / 2 Access not recorded — left out of this score
Points 51 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 51 of the 98 points we could judge it on is 52 out of 100.
Total 52 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Genetics from nearby years

Also tagged “precursor”

1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Genetics

See all studies in Genetics →